Feasibility of engineered Bacillus subtilis for use as a microbiome‐based topical drug delivery platform

• Päätekijät: Veronica A. Montgomery (Tekijä), Amy J. Wood‐Yang (Tekijä), Mark P. Styczynski (Tekijä), Mark R. Prausnitz (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Wiley, 2024-07-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Non‐adherence to medication is a major challenge in healthcare that results in worsened treatment outcomes for patients. Reducing the frequency of required administrations could improve adherence but is challenging for topical drug delivery due to the generally short residence time of topic...